Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
 
VC-funded Company:


PanOptica
150 Morristown Road, Suite 205
Bernardsville, NJ 07924
Phone: 908-766-2202
http://panopticapharma.com/

PanOptica, Inc., is a private biopharmaceutical company focused on developing innovative ophthalmology therapies. Investors include Third Rock Ventures, Novo Ventures, and SV Life Sciences. The company was co-founded by Paul Chaney, past president of OSI-Eyetech, and Martin Wax, MD, a noted academic clinician scientist working in glaucoma, and most recently vice president of research and development and head of ophthalmology discovery and pre-clinical development at Alcon Labs, Inc. The company seeks early-stage assets translated from other diseases and develops select candidates through human clinical proof of concept.

Key Contact
NameTitleE-Mail
Paul G. ChaneyCEO


Funding Events
DateAmountTypeInvestors
10/09/17$11,000,000Series B SV Life Sciences
Third Rock Ventures
 
Massinvestor/VC News Daily
617-620-4606


© 2017 Massinvestor, Inc.